St Helen's Private Equity (Investments) Ltd investment portfolio

Accel‑Heal Technologies Limited develops and supplies a single‑use, wearable micro‑current electrical stimulation device designed to treat painful, hard‑to‑heal chronic wounds such as leg ulcers. Its target market includes clinicians and patients across healthcare settings who manage chronic wound care.

Morvus Technology Limited discovers, develops and commercialises novel oncology drugs and diagnostics, including an inhaled anti‑tumour agent for lung and skin cancers. Its business model centres on out‑licensing its intellectual property to pharmaceutical and biotech companies in exchange for signature fees, milestones and royalties.